Jack Bendheim, President and CEO, 10% Owner at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 45,636 shares at $51.66 ($2.4M) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Scheduled sale ($2.4M) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.66 | 5,280 | $273K | 11.4% |
| 2 | $51.66 | 5,280 | $273K | 11.4% |
| 3 | $51.80 | 4,311 | $223K | 9.3% |
| 4 | $51.80 | 4,311 | $223K | 9.3% |
| 5 | $53.03 | 3,598 | $191K | 8.0% |
| 6 | $53.03 | 3,598 |
| $191K |
| 8.0% |
| 7 | $53.64 | 2,651 | $142K | 5.9% |
| 8 | $53.64 | 2,651 | $142K | 5.9% |
| 9 | $51.78 | 1,939 | $100K | 4.2% |
| 10 | $51.78 | 1,939 | $100K | 4.2% |
| 11 | $52.79 | 4,977 | $263K | 11.0% |
| 12 | $52.79 | 4,977 | $263K | 11.0% |
| 13 | $53.24 | 124 | $7K | 0.3% |
| Total | $52.39 avg | 45,636 | $2.4M | 100% |
| Filing → |
| PAHC | SELL | 2026-04-23 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-04-16 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-03-31 | $1.5M | — | Filing → |